A detailed history of Oarsman Capital, Inc. transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Oarsman Capital, Inc. holds 911 shares of TMO stock, worth $470,167. This represents 0.11% of its overall portfolio holdings.

Number of Shares
911
Previous 879 3.64%
Holding current value
$470,167
Previous $486,000 15.84%
% of portfolio
0.11%
Previous 0.11%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$531.86 - $624.21 $17,019 - $19,974
32 Added 3.64%
911 $563,000
Q2 2024

Aug 12, 2024

SELL
$541.52 - $599.02 $8,664 - $9,584
-16 Reduced 1.79%
879 $486,000
Q1 2024

May 15, 2024

BUY
$528.82 - $599.43 $13,749 - $15,585
26 Added 2.99%
895 $520,000
Q4 2023

Feb 16, 2024

BUY
$431.41 - $532.94 $145,816 - $180,133
338 Added 63.65%
869 $461,000
Q3 2023

Oct 27, 2023

BUY
$498.29 - $574.41 $20,429 - $23,550
41 Added 8.37%
531 $268,000
Q2 2023

Aug 10, 2023

BUY
$508.46 - $591.13 $14,236 - $16,551
28 Added 6.06%
490 $255,000
Q1 2023

May 11, 2023

BUY
$535.0 - $604.82 $247,170 - $279,426
462 New
462 $266,000

Others Institutions Holding TMO

About THERMO FISHER SCIENTIFIC INC.


  • Ticker TMO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 391,788,992
  • Market Cap $202B
  • Description
  • Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...
More about TMO
Track This Portfolio

Track Oarsman Capital, Inc. Portfolio

Follow Oarsman Capital, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oarsman Capital, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Oarsman Capital, Inc. with notifications on news.